busPIRone HCl
- Product NDC
- 72888-062
- 11-digit product format
- 728880062
- Labeler code
- 72888
- Product ID
- 72888-062_47c7577d-5093-5361-e063-6294a90ae76f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- buspirone hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Advagen Pharma Ltd
- Application
- ANDA075521
- Marketing category
- ANDA
- Marketing start
- 2020-12-29
- Substance
- BUSPIRONE HYDROCHLORIDE
- Active strength
- 5 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- busPIRone HCl
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BUSPIRONE HYDROCHLORIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 207LT9J9OC |
| Rxcui | 866018, 866083, 866090, 866094, 866111 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72888-062-01 | busPIRone HCl | 100 in 1 BOTTLE | TABLET | 100 | | 5 |
| 72888-062-05 | busPIRone HCl | 500 in 1 BOTTLE | TABLET | 500 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72888-062 | BUSPIRONE HCL (BUSPIRONE HYDROCHLORIDE) TABLET [ADVAGEN PHARMA LTD] | 4 | Current NDC, Legacy NDC, 2 package rows | 20230120_07a789a9-c9e8-4737-a56d-7d5405fe8100.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72888-062-01 | 72888006201 | 100 TABLET in 1 BOTTLE (72888-062-01) | 100 tablet | 2020-12-29 | 0000-00-00 | No | No | Current |
| 72888-062-05 | 72888006205 | 500 TABLET in 1 BOTTLE (72888-062-05) | 500 tablet | 2020-12-29 | 0000-00-00 | No | No | Current |